Answer:
The correct answer would be meiosis.
In diploid organisms, meiosis is the process that results in the formation of four haploid daughter cells from single diploid parent cell. Each of the daughter cell contains half the number of chromosomes present in parent cell.
It results in the formation of haploid gametes (sperm in males and eggs in females) which is essential in the process of sexual reproduction.
The fusion of gametes results in the formation of diploid zygote that is, maintains the diploid nature of the organism.
Hence, in absence of meiotic division the chromosomal number would keep on doubling after each generation.
In addition, crossing over (exchange of genetic material between non-sister chromatids) also takes in the prophase-I of meiosis I. It increases the genetic variation within organisms of the species. It may add survival adaptations to the population.
Is this the OSHA bloodborne??
if so id there answer choices
Answer:
1. Ants, termites, and bees
Explanation:
Eusocial societies are common in insects. This type of behaviour is characterized by the fact that individuals fall into certain groups with certain behaviours. For example, think of worker bees and the queen bee. These societies are associated with a few features:
- the offspring are cared for by individuals other than the parents -many members in the group can cooperate to take care of the young.
- labour is divided into reproductive and non-reproductive groups. Only the reproductive individuals are able to have offspring, the others help with parental care, gathering food, and maintaining shelter.
- this creates groups, sometimes called 'castes', that animals fall into. They do not deviate from these groups once they are established.
The answer would be evolution, the creature must evolve and adapt to survive.
<span>A drug used to treat CML, imatinib, binds to the active site of Abl kinase. Why does this drug work to treat this type of cancer?
</span><span>B) By binding to the active site, the drug prevents the ability of Abl kinase to bind to its substrate.
</span>
Imatinib works against CML by binding close to the ATP binding site of bcr-abl. The binding results to the<span> locking in of the bcr-abl to a closed or self-inhibited conformation and inhibiting the enzyme activity of the protein </span><span>semi-competitively.</span>
